CVS Caremark Announces Agreement with FTC To Further Advance Industry-Leading Approaches to Transparency and Affordability
The deal resolves FTC litigation and could bring billions in savings, while CVS says 25 million Americans got nearly $900 million in savings last year.
- On Tuesday, July 14, 2026, CVS Caremark finalized a settlement with the Federal Trade Commission requiring the pharmacy benefits manager to curb rebates and count consumers' TrumpRx purchases toward deductibles.
- The FTC launched suits in 2024 against PBM giants CVS Caremark, Express Scripts, and Optum Rx, alleging business practices that inflate drug prices and disadvantage independent pharmacies.
- FTC Chairman Andrew Ferguson estimated the settlement will save consumers up to $8.5 billion over the next decade, with another $4.5 billion from point-of-sale rebates alone.
- Caremark President Ed DeVaney said the agreement reinforces existing affordability efforts, though the settlement includes no monetary penalties while mandating that Caremark prefer lowest-cost drugs on standard formularies.
- Together, the three major PBMs control about 80% of U.S. prescriptions, prompting voluntary industry moves toward rebate-free models as companies aim to avoid further legislative or regulatory action.
11 Articles
11 Articles
For months, CVS didn’t count certain Rx purchases toward deductibles. Now, that’s changing
Every dollar spent on discounted Ozempic, Wegovy or dozens of other drugs through TrumpRx.gov has done nothing to help patients meet their insurance deductible for more than five months.
CVS Caremark Settles FTC Case, Agrees to Reform Drug Rebates and TrumpRx Payments
CVS Health’s pharmacy benefit manager Caremark has reached a settlement with the U.S. Federal Trade Commission (FTC) that will change how it handles drug discounts, rebates, and payments made through President Donald Trump’s TrumpRx program. TrumpRx is the government clearinghouse for consumer prescription drug purchases, launched earlier this year. The FTC said on July 14 that Caremark Rx and Zinc Health Services (collectively Caremark) have ag…
CVS Caremark Announces Agreement with FTC To Further Advance Industry-Leading Approaches to Transparency and Affordability
WOONSOCKET, R.I., July 14, 2026 /PRNewswire/ -- CVS Caremark today announced a global settlement with the Federal Trade Commission (FTC) which further advances the company's leadership in delivering greater affordability for prescription drugs. The settlement resolves all outstanding FTC litigation…
CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance
By Amina Niasse and Jody Godoy NEW YORK, July 14 (Reuters) - CVS Health's Caremark has finalized a settlement with the U.S. Federal Trade Commission in which it agreed to curb use of after-market discounts known as rebates and count consumers' TrumpR...
Coverage Details
Bias Distribution
- 78% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
